Summary
The author proposes to include in a new class of drugs: the “thioloprive drugs,” all those substances which react in one way or another, with the thiol functions of proteins, cysteine or glutathione. This class includes oxidizing agents, heavy metals, maleic acid and halogenated organic substances like mustard gas, lewisite or monoiodoacetic acid. The creation of this new pharmacological family is justified by the fact that these varied substances have many common toxic effects (Lundsgaard contracture, cytotoxic action, œdema), that they inhibit the same enzymes, and that a logical interpretation of many of their actions is possible on the basis of their reaction with the thiol groups.
Similar content being viewed by others
References
E. Lundsgaard, Biochem. Z.217, 162 (1930) et227, 51 (1930).
Z. M. Bacq etM. Goffart, C. r. Soc. Biol.133, 694 et 696 (1940).
Z. M. Bacq, M. Goffart etP. Angenot, Bull. Acad. Roy. Med. Belg. 255 (1940).
J. Godeaux, Bull. Soc. Roy. Sci. Liége 692 (1943).
Z. M. Bacq, M. Goffart etP. Angenot, Bull. Acad. Roy. Med. Belg. 255 (1940).
Z. M. Bacq, Bull. Acad. Roy. Med. Belg. 108 (1942).
O. Krayer, R. P. Linstead etD. Todd, J. Pharm. exper. Ther.77, 113 (1943).
O. Krayer, Proc. Soc. exper. Biol. Med.53, 51 (1943).
R. Mendez, J. Pharm. exper. Ther.81, 151 (1944).
Z. M. Bacq, Bull. Acad. Roy. Med. Belg., 108 (1942).
Z. M. Bacq, Acta biol. Belg.2, 253 (1942).
J. Godeaux, Bull. Soc. Roy. Sci. Liége, 216 (1944).
Z. M. Bacq, Bull. Acad. Roy. Med. Belg. 108 (1942).
Z. M. Bacq, Bull. Acad. Roy. Med. Belg. 108 (1942).
Z. M. Bacq, M. Goffart etP. Angenot, Bull. Acad. Roy. Med. Belg. 255 (1940).
Z. M. Bacq etM. Goffart, Acta biol. Belg.1, 33 (1941).
O. Muntsch, Leitfaden der Pathologie und Therapie der Kampfstofferkrankungen, Thieme, Leipzig 1941.
A. Rühl etS. Thaddea, Z. exper. Med.100, 306 (1937).
W. Feldberg etC. H. Kellaway, Australian J. exper. Biol. med. Sci.16, 249 (1938).
W. Heubner, Heffter Handb. exper. Pharm.III, 3, 2020 (1934).
B. v. Issekutz etI. Mehes, Arch. exper. Path. Pharm.152, 318 (1930).
F. Flury, Heffter Handb. exper. Pharm.III, 3, 1885 (1934).
I. Berenblum, L. P. Kendall etG. W. Orr, Biochem. J.30, 709 (1936).
A. Gilman etF. S. Philips, Science103, 409 (1946).
F. S. Hammett, Protoplasma13, 331 (1931).
W. Richter, Kampfstoffwirkung und Heilung, J. A. Barth, Leipzig 1941.
W. Feldberg etC. H. Kellaway, Australian J. exper. Biol. med. Sci.16, 249 (1938).
A. Gilman etF. S. Philips, Science103, 409 (1946).
I. Berenblum etA. Wormall, Biochem. J.33, 75 (1939).
V. Desreux, E. Fredericq etP. Fischer, Bull. Soc. Chim. biol., sous presse (1946).
Z. M. Bacq, Enzymologia10, 48 (1941).
Z. M. Bacq, M. Goffart etP. Angenot, Bull. Acad. Roy. Med. Belg. 255 (1940).
Z. M. Bacq, Arch. int. Pharm. Ther.63, 59 (1939) et67, 323 (1942).
Z. M. Bacq etG. Coppée, Arch. int. Physiol.51, 35 (1941).
R. A. Peters, L. A. Stocken etR. H. S. Thompson, Nature156, 616 (1945).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bacq, Z.M. Substances thioloprives. Experientia 2, 385–390 (1946). https://doi.org/10.1007/BF02154210
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02154210